BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
Not yet recruiting · NCT06347458 · Registry updated 2024-04-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2024-04-04 | NCT06347458 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Bio-gene Technology Co., Ltd | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||